120 related articles for article (PubMed ID: 20007071)
41. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma.
Andea A; Sarkar F; Adsay VN
Mod Pathol; 2003 Oct; 16(10):996-1006. PubMed ID: 14559982
[TBL] [Abstract][Full Text] [Related]
42. Primary pancreatic tuberculosis masquerading as a pancreatic tumor leading to Whipple's pancreaticoduodenectomy. A case report and review of the literature.
Singh DK; Haider A; Tatke M; Kumar P; Mishra PK
JOP; 2009 Jul; 10(4):451-6. PubMed ID: 19581756
[TBL] [Abstract][Full Text] [Related]
43. Strategies for the treatment of invasive ductal carcinoma of the pancreas and how to achieve zero mortality for pancreaticoduodenectomy.
Kimura W
J Hepatobiliary Pancreat Surg; 2008; 15(3):270-7. PubMed ID: 18535764
[TBL] [Abstract][Full Text] [Related]
44. Intraductal papillary components in invasive ductal carcinoma of the pancreas are associated with long-term survival of patients.
Fukushima N; Sakamoto M; Mukai K; Kanai Y; Shimada K; Kosuge T; Hirohashi S
Hum Pathol; 2001 Aug; 32(8):834-41. PubMed ID: 11521228
[TBL] [Abstract][Full Text] [Related]
45. Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas.
Nakagohri T; Asano T; Kenmochi T; Urashima T; Ochiai T
World J Surg; 2002 Sep; 26(9):1166-9. PubMed ID: 12045867
[TBL] [Abstract][Full Text] [Related]
46. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
[TBL] [Abstract][Full Text] [Related]
47. Long-term survival after pancreatoduodenectomy for ductal adenocarcinoma: the emperor has no clothes?
Bradley EL
Pancreas; 2008 Nov; 37(4):349-51. PubMed ID: 18953246
[No Abstract] [Full Text] [Related]
48. Intraductal papillary mucinous tumors of the pancreas. Surgical treatment: at what point should we stop?
Salvia R; Bassi C; Falconi M; Serini P; Crippa S; Capelli P; Pederzoli P
JOP; 2005 Jan; 6(1 Suppl):112-7. PubMed ID: 15650295
[TBL] [Abstract][Full Text] [Related]
49. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
[TBL] [Abstract][Full Text] [Related]
50. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.
Zhou GW; Wu WD; Xiao WD; Li HW; Peng CH
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937
[TBL] [Abstract][Full Text] [Related]
51. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
[TBL] [Abstract][Full Text] [Related]
52. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
[TBL] [Abstract][Full Text] [Related]
53. Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer.
Javle MM; Gibbs JF; Iwata KK; Pak Y; Rutledge P; Yu J; Black JD; Tan D; Khoury T
Ann Surg Oncol; 2007 Dec; 14(12):3527-33. PubMed ID: 17879119
[TBL] [Abstract][Full Text] [Related]
54. Comparative study between uncinate process carcinoma and pancreatic head carcinoma after pancreaticodudenectomy (clincopathological features and surgical outcomes).
El Nakeeb A; Roshdy S; Ask W; Sonbl A; Ali M; Abdelwahab K; Shams N; Abdelwahab M
Hepatogastroenterology; 2014 Sep; 61(134):1748-55. PubMed ID: 25436374
[TBL] [Abstract][Full Text] [Related]
55. Pancreatic resection for metastatic tumors to the pancreas.
Sperti C; Pasquali C; Liessi G; Pinciroli L; Decet G; Pedrazzoli S
J Surg Oncol; 2003 Jul; 83(3):161-6; discussion 166. PubMed ID: 12827684
[TBL] [Abstract][Full Text] [Related]
56. Comparison of clinicopathological characteristics of curatively resected pancreatic head and body/tail ductal cancers.
Nakata B; Yamada N; Amano R; Tendo M; Inoue M; Sakurai K; Hirakawa K
J Exp Clin Cancer Res; 2007 Dec; 26(4):459-66. PubMed ID: 18365539
[TBL] [Abstract][Full Text] [Related]
57. The vascular stapler in uncinate process division during pancreaticoduodenectomy: technical considerations and results.
D'souza MA; Singh K; Hawaldar RV; Shukla PJ; Shrikhande SV
Dig Surg; 2010 Aug; 27(3):175-81. PubMed ID: 20571262
[TBL] [Abstract][Full Text] [Related]
58. [The role of full length superior mesenteric artery isolation in extended pancreaticoduodenectomy in the treatment of ductal adenocarcinoma of the pancreas in the uncinate process].
Zhang YJ; Hu XG; Jin G; Shao CH; He TL; Li G; Jing W; Song B
Zhonghua Wai Ke Za Zhi; 2009 Nov; 47(21):1627-9. PubMed ID: 20137396
[TBL] [Abstract][Full Text] [Related]
59. Surgical management in patients with pancreatic cancer: a Queensland perspective.
Wylie N; Adib R; Barbour AP; Fawcett J; Hill A; Lynch S; Martin I; O'Rourke TR; Puhalla H; Rutherford L; Slater K; Whiteman DC; Neale RE;
ANZ J Surg; 2013 Nov; 83(11):859-64. PubMed ID: 23095039
[TBL] [Abstract][Full Text] [Related]
60. Pancreaticoduodenectomy and its variants.
Wolf AM; Lavu H
Cancer J; 2012; 18(6):555-61. PubMed ID: 23187842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
